Anti-KLK2 Antibody

Produced in rabbit and supplied as 100 µl of unconjugated polyclonal antiserum, this Anti-KLK2 reagent from Antibodies.com specifically targets Kallikrein-2, a serine protease most prominently expressed in prostatic epithelium and widely studied as a prostate cancer biomarker alongside PSA (KLK3).

Validated for Western blot (WB) and immunohistochemistry (IHC) on human samples, the antibody supports detection of endogenous KLK2 in cell lysates and formalin-fixed tissue sections. Altered KLK2 expression has been documented in prostate tumor tissue relative to benign controls, and researchers investigating kallikrein pathway biology, biomarker validation, or comparative KLK2 versus PSA profiling in benign versus malignant prostate specimens routinely employ such polyclonal antibodies in their WB and IHC workflows.